As drug development becomes more complex, the rise of "Specialty CROs" has become a defining feature of the preclinical market. These organizations focus on specific therapeutic areas, such as Central Nervous System (CNS) disorders, ophthalmology, or infectious diseases. Niche CROs often possess specialized equipment—such as high-field MRI for neuroimaging or BSL-3 labs for pathogen...